Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
NCT02303028
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Topotecan and Pazopanib
Sponsor
The Hospital for Sick Children
Collaborators
[object Object]